Ye of little faith, and that has always been apparent. This much we know about you.
I do feel we have a pathway to success in many directions. You can call it what you want. But Covid will be our first EUA and quite possibly our first full approval. It may not be here. But other countries don’t have our political bearing on their approval process. I am betting U.K. is our first EUA or PIM as they call it. Probably our first full Approval also.
One thing I have learned. It’s hard for a little company to rub elbows with big companies that have tons of money to throw out there to slow everyone else down to a crawl. Maybe our new strategy of having our doctor visiting every open trial site will show that money isn’t everything and letting our little molecule compete is well deserving and life changing if they actually use Leronlimab. I see this pathway well lit now and a faster trial because of this extra effort of our doctor beating down the door of trial hospitals.
I see a better pathway forward for our cancer trials with extra testing for more markers and for someone to help us get our BTD there. I just feel that Dr. Mahboob Rahman will not disappoint us. It is the single best thing we have done as a company this year is to hire someone to bring us the experience of completing a BLA or complete the filing of a indication that gets approval. Cancer is a great path for Leronlimab. Today we had Dr. Patterson’s tweet shows you his opinion is still very high of Leronlimab for cancer among other indications too.
I also like very much the starting of other block buster potential indications like NASH and Alzheimer’s and starting of protocols for Long Haulers and maybe Moderate Covid patients by end of 2021.
So you can be negative and see a slow process somehow seem slower than we all like or want. The real bone you can chew on is that we aren’t a one show drug. We will have indications get approval if we can just get over the hump and get that first approval. I believe a Covid approval is soon. I believe our cancer trials will be proven to extend lives. I believe we are doing the right thing to start the trials as soon as possible for other indications that are life saving and possibly BTD or label extensions instead of approvals. It’s just getting that first one that’s taking forever. But we are closer and closer all the time.
We are early and under budget so we have a great path already. Getting our first approval will be not that far in the future. That’s the reason(s) I have faith. We as a company are not a one pony show. We have options and directions to achieve our end goals. It’s hard for me to get discouraged when everything seems to be coming together. With trial results we think we have and never taking a step backwards of safety or efficacy. It’s not IF... it’s when!
I haven’t sold one share in the past year. I watch and I watch. It went up and it went down. I never stopped believing. Dr. Patterson’s Ted Talkx locked me into... it’s just a matter of time. Time is something I have. So I like you... Wait... but time is narrowing and it’s much closer than we know.
I do feel we have a pathway to success in many directions. You can call it what you want. But Covid will be our first EUA and quite possibly our first full approval. It may not be here. But other countries don’t have our political bearing on their approval process. I am betting U.K. is our first EUA or PIM as they call it. Probably our first full Approval also.
One thing I have learned. It’s hard for a little company to rub elbows with big companies that have tons of money to throw out there to slow everyone else down to a crawl. Maybe our new strategy of having our doctor visiting every open trial site will show that money isn’t everything and letting our little molecule compete is well deserving and life changing if they actually use Leronlimab. I see this pathway well lit now and a faster trial because of this extra effort of our doctor beating down the door of trial hospitals.
I see a better pathway forward for our cancer trials with extra testing for more markers and for someone to help us get our BTD there. I just feel that Dr. Mahboob Rahman will not disappoint us. It is the single best thing we have done as a company this year is to hire someone to bring us the experience of completing a BLA or complete the filing of a indication that gets approval. Cancer is a great path for Leronlimab. Today we had Dr. Patterson’s tweet shows you his opinion is still very high of Leronlimab for cancer among other indications too.
I also like very much the starting of other block buster potential indications like NASH and Alzheimer’s and starting of protocols for Long Haulers and maybe Moderate Covid patients by end of 2021.
So you can be negative and see a slow process somehow seem slower than we all like or want. The real bone you can chew on is that we aren’t a one show drug. We will have indications get approval if we can just get over the hump and get that first approval. I believe a Covid approval is soon. I believe our cancer trials will be proven to extend lives. I believe we are doing the right thing to start the trials as soon as possible for other indications that are life saving and possibly BTD or label extensions instead of approvals. It’s just getting that first one that’s taking forever. But we are closer and closer all the time.
We are early and under budget so we have a great path already. Getting our first approval will be not that far in the future. That’s the reason(s) I have faith. We as a company are not a one pony show. We have options and directions to achieve our end goals. It’s hard for me to get discouraged when everything seems to be coming together. With trial results we think we have and never taking a step backwards of safety or efficacy. It’s not IF... it’s when!
I haven’t sold one share in the past year. I watch and I watch. It went up and it went down. I never stopped believing. Dr. Patterson’s Ted Talkx locked me into... it’s just a matter of time. Time is something I have. So I like you... Wait... but time is narrowing and it’s much closer than we know.
13
